Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy.

MLA

Lin, Ying-Cheng, et al. “Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy.” Journal of Clinical Medicine, vol. 10, no. 15, July 2021. EBSCOhost, https://doi.org/10.3390/jcm10153296.

APA

Lin, Y.-C., Chen, Y.-J., Lee, S.-W., Lee, T.-Y., Chen, Y.-H., Huang, W.-N., Yang, S.-S., & Chen, Y.-M. (2021). Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy. Journal of Clinical Medicine, 10(15). https://doi.org/10.3390/jcm10153296

Chicago

Lin, Ying-Cheng, Yen-Ju Chen, Shou-Wu Lee, Teng-Yu Lee, Yi-Hsing Chen, Wen-Nan Huang, Sheng-Shun Yang, and Yi-Ming Chen. 2021. “Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy.” Journal of Clinical Medicine 10 (15). doi:10.3390/jcm10153296.